Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Viral Gastroenteritis Panel Detects Norovirus in Two Hours

By Labmedica staff writers
Posted on 30 Jan 2008
New rapid enzyme immunoassays can be used to detect the four leading causes of viral gastroenteritis: Norovirus, Rotavirus, astrovirus, and adenovirus, in human stool samples.
Detection of Norovirus is of particular concern due to a rapid increase in its activity in Europe and the United States.

Rapid identification of the etiologic agent combined with appropriate infection control procedures can help to reduce the impact of Norovirus outbreaks in the institution involved. More...
The IDEIA Norovirus immunoassay allows the virus to be detected in stool samples within just two hours.

Each IDEIA viral gastroenteritis kit follows the same standardized protocol and is suitable for manual or automated testing. The assays are quick and easy to perform, either individually or in a panel using a single sample dilution. Sensitive and specific results are read photometrically.

Barbara Fallowfield, marketing manager, Oxoid (Basingstoke, UK), the company that launched the IDEIA Norovirus kit commented, "The sooner the cause of gastroenteritis outbreaks can be detected, the sooner infection control procedures can be put in place to stop the spread of disease and limit the damage. IDEIA Norovirus provides rapid and reliable results that are of enormous value to those involved in the investigation and prevention of Norovirus outbreaks, including microbiology laboratories, infection control teams, surveillance teams, and cruise ship operators.


Related Links:
Oxoid

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.